The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in

Status Completed

Clinical Trial Summary

To determine if emergency department patients with acute ureteral colic pain due to a ureteral stone who are treated with tamsulosin, versus placebo, will experience a shorter time to passage of their stone or resolution of their pain. A secondary study objective will be to determine if there is a relationship between response to tamsulosin and stone size or position in the ureter.

Clinical Trial Description

This is a prospective randomized placebo controlled study of tamsulosin alone, vs placebo, to determine its effect on the rates of stone passage and resolution of pain in patients with acute renal colic pain that present to the emergency department. The study will be conducted in the Emergency Department (ED)and Emergency Department Observation Unit (EDOU) of William Beaumont Hospital, a high volume, university affiliated 952 bed suburban teaching hospital.

Patients will be given a seven-day supply of tamsulosin (0.4mg daily) or placebo. They will also be given a prescription for Vicodin (30 pills) and Ibuprofen (600mg, 30 pills). They will be called on days 1, 2, 3, 7, and 10 following the index visit regarding passage of stone or 48 hours without pain. Patients will be asked to call in if they pass their stone or are without pain for 48 hours. Related return visits to Royal Oak or Troy Beaumont within 30 days of their index visit will be followed by chart review.

The study will be limited to patients presenting to the emergency department with acutely symptomatic renal colic pain. Confirmation of a symptomatic stone will be made by imaging (helical CT scan or intravenous pyelogram).

Study exclusion criteria:

- Stone not documented on imaging

- Stones >10mm

- Pregnancy

- Age <18 years

- Evidence of infection with an obstructing stone

- Obstructing stone in a solitary kidney

- Currently taking tamsulosin, vardenafil, nifedipine, or steroids

- Contraindications or allergy to tamsulosin

- Ureteral surgery

- Patients that are unable to understand consent

- Patients that are unable to comply with follow-up ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00448123
Study type	Interventional
Source	William Beaumont Hospitals
Contact
Status	Completed
Phase	N/A
Start date	February 2007
Completion date	September 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02547805` - Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days	Phase 2
Completed	`NCT02579161` - Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy	Phase 3
Completed	`NCT01187745` - Study to Look for Artifact on Computed Tomography (CT) Representing Kidney Stones	N/A
Withdrawn	`NCT00875823` - International Registry for Primary Hyperoxaluria	N/A
Completed	`NCT05519150` - Donors With Nephrolithiasis at the Time of Transplant Evaluation (DONATE). Long Term Follow-up.
Recruiting	`NCT02522689` - Comparison of Ultra-mini PCNL and Micro PCNL	N/A
Recruiting	`NCT01514032` - Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones	N/A
Completed	`NCT00765128` - Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy	Phase 4
Completed	`NCT00873054` - Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy	N/A
Withdrawn	`NCT00583258` - A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones	N/A
Active, not recruiting	`NCT03630926` - Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
Not yet recruiting	`NCT02214836` - Ultrasound Imaging of Kidney Stones and Lithotripsy	N/A
Completed	`NCT03095885` - A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria	N/A
Completed	`NCT01330940` - Effect of Diet Orange Soda on Urinary Lithogenicity	N/A
Completed	`NCT01088555` - Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers	N/A
Recruiting	`NCT00489723` - Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?	N/A
Recruiting	`NCT05417568` - Oxalate-Driven Host Responses in Kidney Stone Disease	N/A
Recruiting	`NCT02375295` - Struvite Stones Antibiotic Study	Phase 4
Enrolling by invitation	`NCT02408211` - Preoperative Antibiotic PNL Study	Phase 4
Withdrawn	`NCT01560091` - Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms